• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Vav的酪氨酸磷酸化诱导及Pim-1的表达与Jak2介导的来自促红细胞生成素受体的生长信号传导相关。

Induction of tyrosine phosphorylation of Vav and expression of Pim-1 correlates with Jak2-mediated growth signaling from the erythropoietin receptor.

作者信息

Miura O, Miura Y, Nakamura N, Quelle F W, Witthuhn B A, Ihle J N, Aoki N

机构信息

First Department of Internal Medicine, Tokyo Medical and Dental University, Japan.

出版信息

Blood. 1994 Dec 15;84(12):4135-41.

PMID:7527668
Abstract

The receptor for erythropoietin (Epo) belongs to the cytokine receptor family and lacks a tyrosine kinase domain. However, it has been hypothesized that a tyrosine kinase, Jak2, associates with the membrane proximal cytoplasmic region of Epo receptor (EpoR) and mediates the growth signaling from the receptor through tyrosine phosphorylation of cellular substrates. To explore the growth signaling pathways from the EpoR, we analyzed substrates of tyrosine phosphorylation induced by Epo stimulation in cells expressing various mutant EpoRs. The vav proto-oncogene product was found to be tyrosine phosphorylated after Epo stimulation in cells expressing the wild-type EpoR or a truncated receptor, H mutant, that retains the growth signaling function. In these cells, Epo also induced the expression of a serine/threonine kinase, Pim-1. However, Epo stimulation did not have any effect on Vav or Pim-1 in cells expressing a mutant EpoR, PM4 mutant, inactivated by a point mutation, Trp282 to Arg, in the membrane proximal region, which abrogates the interaction with Jak2. On the other hand, both tyrosine phosphorylation of Vav and expression of Pim-1 were observed constitutively in cells expressing a mutant EpoR that is constitutively activated by a point mutation, Arg 129 to Cys, in the extracellular domain. Jak2 was also constitutively tyrosine phosphorylated and activated in cells expressing this mutant, which confirms the crucial role of Jak2 in growth signaling from the EpoR. Taken together, these observations suggest that the tyrosine phosphorylation of Vav and the expression of Pim-1 may play important roles in growth signaling from the EpoR.

摘要

促红细胞生成素(Epo)受体属于细胞因子受体家族,缺乏酪氨酸激酶结构域。然而,据推测,一种酪氨酸激酶Jak2与Epo受体(EpoR)膜近端的胞质区域相关联,并通过细胞底物的酪氨酸磷酸化介导来自该受体的生长信号。为了探究来自EpoR的生长信号通路,我们分析了在表达各种突变型EpoR的细胞中,Epo刺激诱导的酪氨酸磷酸化底物。在表达野生型EpoR或保留生长信号功能的截短受体H突变体的细胞中,发现vav原癌基因产物在Epo刺激后发生酪氨酸磷酸化。在这些细胞中,Epo还诱导了丝氨酸/苏氨酸激酶Pim-1的表达。然而,在表达因膜近端区域的点突变(Trp282突变为Arg)而失活的突变型EpoR(PM4突变体)的细胞中,Epo刺激对Vav或Pim-1没有任何影响,该点突变消除了与Jak2的相互作用。另一方面,在表达因胞外结构域的点突变(Arg 129突变为Cys)而组成性激活的突变型EpoR的细胞中,Vav的酪氨酸磷酸化和Pim-1的表达均持续存在。在表达这种突变体的细胞中,Jak2也持续发生酪氨酸磷酸化并被激活,这证实了Jak2在来自EpoR的生长信号中的关键作用。综上所述,这些观察结果表明,Vav的酪氨酸磷酸化和Pim-1的表达可能在来自EpoR的生长信号中发挥重要作用。

相似文献

1
Induction of tyrosine phosphorylation of Vav and expression of Pim-1 correlates with Jak2-mediated growth signaling from the erythropoietin receptor.Vav的酪氨酸磷酸化诱导及Pim-1的表达与Jak2介导的来自促红细胞生成素受体的生长信号传导相关。
Blood. 1994 Dec 15;84(12):4135-41.
2
Erythropoietin induces association of the JAK2 protein tyrosine kinase with the erythropoietin receptor in vivo.促红细胞生成素在体内诱导JAK2蛋白酪氨酸激酶与促红细胞生成素受体结合。
Blood. 1994 Sep 1;84(5):1501-7.
3
Erythropoietin induces tyrosine phosphorylation of the interleukin-3 receptor beta subunit (betaIL3) and recruitment of Stat5 to possible Stat5-docking sites in betaIL3.促红细胞生成素诱导白细胞介素-3受体β亚基(βIL3)的酪氨酸磷酸化,并使Stat5募集至βIL3中可能的Stat5对接位点。
Blood. 1997 Jun 15;89(12):4327-36.
4
A human erythropoietin receptor gene mutant causing familial erythrocytosis is associated with deregulation of the rates of Jak2 and Stat5 inactivation.一种导致家族性红细胞增多症的人类促红细胞生成素受体基因突变体与Jak2和Stat5失活速率的失调有关。
Exp Hematol. 1999 Jan;27(1):63-74. doi: 10.1016/s0301-472x(98)00003-4.
5
Activation of the mitogen-activated protein kinase pathway by the erythropoietin receptor.促红细胞生成素受体对丝裂原活化蛋白激酶途径的激活。
J Biol Chem. 1994 Nov 25;269(47):29962-9.
6
Tyrosine 425 within the activated erythropoietin receptor binds Syp, reduces the erythropoietin required for Syp tyrosine phosphorylation, and promotes mitogenesis.活化的促红细胞生成素受体中的酪氨酸425与Syp结合,减少Syp酪氨酸磷酸化所需的促红细胞生成素,并促进有丝分裂。
Blood. 1996 Jun 1;87(11):4495-501.
7
CrkL is recruited through its SH2 domain to the erythropoietin receptor and plays a role in Lyn-mediated receptor signaling.CrkL 通过其 SH2 结构域被招募到促红细胞生成素受体,并在 Lyn 介导的受体信号传导中发挥作用。
J Biol Chem. 2001 Aug 31;276(35):33282-90. doi: 10.1074/jbc.M102924200. Epub 2001 Jul 6.
8
Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway.Lyn在物理上与促红细胞生成素受体相关联,可能在Stat5信号通路的激活中发挥作用。
Blood. 1998 May 15;91(10):3734-45.
9
Mitogen-activated protein kinase plays an essential role in the erythropoietin-dependent proliferation of CTLL-2 cells.丝裂原活化蛋白激酶在促红细胞生成素依赖的CTLL-2细胞增殖中起重要作用。
J Biol Chem. 2000 Nov 17;275(46):35857-62. doi: 10.1074/jbc.M006317200.
10
JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin.JAK2与促红细胞生成素受体结合,并在促红细胞生成素刺激后发生酪氨酸磷酸化并被激活。
Cell. 1993 Jul 30;74(2):227-36. doi: 10.1016/0092-8674(93)90414-l.

引用本文的文献

1
Pim Kinases: Important Regulators of Cardiovascular Disease.Pim 激酶:心血管疾病的重要调节因子。
Int J Mol Sci. 2023 Jul 18;24(14):11582. doi: 10.3390/ijms241411582.
2
Targeting macrophagic PIM-1 alleviates osteoarthritis by inhibiting NLRP3 inflammasome activation via suppressing mitochondrial ROS/Cl efflux signaling pathway.靶向巨噬细胞 PIM-1 通过抑制线粒体 ROS/Cl 外排信号通路抑制 NLRP3 炎性小体激活,从而缓解骨关节炎。
J Transl Med. 2023 Jul 8;21(1):452. doi: 10.1186/s12967-023-04313-1.
3
Targeting BET Proteins Downregulates miR-33a To Promote Synergy with PIM Inhibitors in CMML.
靶向 BET 蛋白下调 miR-33a 以促进与 PIM 抑制剂在 CMML 中的协同作用。
Clin Cancer Res. 2023 Aug 1;29(15):2919-2932. doi: 10.1158/1078-0432.CCR-22-3929.
4
The Role of PIM Kinases in Pediatric Solid Tumors.PIM激酶在儿童实体瘤中的作用。
Cancers (Basel). 2022 Jul 22;14(15):3565. doi: 10.3390/cancers14153565.
5
Therapeutic Efficacy of Combined JAK1/2, Pan-PIM, and CDK4/6 Inhibition in Myeloproliferative Neoplasms.联合 JAK1/2、泛 PIM 和 CDK4/6 抑制在骨髓增殖性肿瘤中的治疗疗效。
Clin Cancer Res. 2021 Jun 15;27(12):3456-3468. doi: 10.1158/1078-0432.CCR-20-4898. Epub 2021 Mar 29.
6
FLT3-ITD induces expression of Pim kinases through STAT5 to confer resistance to the PI3K/Akt pathway inhibitors on leukemic cells by enhancing the mTORC1/Mcl-1 pathway.FLT3-ITD通过信号转导和转录激活因子5(STAT5)诱导Pim激酶的表达,通过增强雷帕霉素靶蛋白复合体1(mTORC1)/髓细胞白血病-1(Mcl-1)信号通路,使白血病细胞对PI3K/Akt信号通路抑制剂产生抗性。
Oncotarget. 2017 Dec 4;9(10):8870-8886. doi: 10.18632/oncotarget.22926. eCollection 2018 Feb 6.
7
JAK2 inhibitors for myeloproliferative neoplasms: what is next?用于骨髓增殖性肿瘤的JAK2抑制剂:下一步是什么?
Blood. 2017 Jul 13;130(2):115-125. doi: 10.1182/blood-2017-04-742288. Epub 2017 May 12.
8
Developmental stage-specific effects of Pim-1 dysregulation on murine bone marrow B cell development.Pim-1失调对小鼠骨髓B细胞发育的发育阶段特异性影响。
BMC Immunol. 2016 Jun 10;17(1):16. doi: 10.1186/s12865-016-0152-1.
9
Intrinsic resistance to PIM kinase inhibition in AML through p38α-mediated feedback activation of mTOR signaling.通过p38α介导的mTOR信号反馈激活,急性髓系白血病对PIM激酶抑制产生内在抗性。
Oncotarget. 2016 Jun 21;7(25):37407-37419. doi: 10.18632/oncotarget.9822.
10
Selective JAK2 inhibition specifically decreases Hodgkin lymphoma and mediastinal large B-cell lymphoma growth in vitro and in vivo.选择性JAK2抑制可特异性降低霍奇金淋巴瘤和纵隔大B细胞淋巴瘤在体外和体内的生长。
Clin Cancer Res. 2014 May 15;20(10):2674-83. doi: 10.1158/1078-0432.CCR-13-3007. Epub 2014 Mar 7.